Drug Profile
Platelet-derived growth factor gene therapy
Latest Information Update: 30 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Gene therapies; Growth factors
- Mechanism of Action Platelet-derived growth factor receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Joint disorders
Most Recent Events
- 23 Sep 1998 Preclinical development for Joint disorders in Japan (Intra-articular)
- 22 Sep 1998 New profile